FDA approves first drug to delay type 1 diabetes

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

FDA approves first drug to delay type 1 diabetes. Read the latest from The Clinical Pipeline, by CyrilPedia

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser . In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eight rules to combat medical misinformation - Nature MedicineAuthors of biomedical research should provide clear and accurate information to society, whilst working to combat misinformation and disinformation. CT_Bergstrom Interesting indeed; I wished the author has addressed the intentional misinformation made by scientists driven by political and ideological prejudices. CT_Bergstrom Carl, you still have good points... but also, you still need to listen to your own advice. Conflating FL's substantive reasons for pursuing its policies with unthouthful, reactionary responses is itself disingenuous and poor communication. Do better. You too, NM! CT_Bergstrom A bunch of glittering generalities with no actual information.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Parkinson’s disease drug hunters think outside the α-synuclein box - Nature BiotechnologyRecent trial failures have called into question the central role of α-synuclein in Parkinson’s disease pathology. Although many continue to target α-synuclein aggregates in the brain, others are paying attention to the endolysosomal pathway, mitochondria and even glucose metabolism.
Source: NatureBiotech - 🏆 231. / 63 Read more »

There Ain't No Medicine! | The Takeaway | WNYC StudiosAs the 'tripledemic' of the flu, RSV, and COVID-19 surges, parts of the country are seeing a medicine shortage, which is especially affecting children's medicines.
Source: WNYC - 🏆 602. / 51 Read more »